Publikationen, an denen er mitarbeitet MIGUEL PAYA PERIS (51)

2006

  1. Marine sponge metabolites for the control of inflammatory diseases

    Current Opinion in Investigational Drugs, Vol. 7, Núm. 11, pp. 974-979

2005

  1. Búsqueda y evaluación de nuevos agentes naturales con actividad antiinflamatoria y antiartrítica

    Revista de fitoterapia, Vol. 5, Núm. 1, pp. 82

  2. Protection against 2,4,6-trinitrobenzenesulphonic acid-induced colonic inflammation in mice by the marine products bolinaquinone and petrosaspongiolide M

    Biochemical Pharmacology, Vol. 69, Núm. 10, pp. 1433-1440

2004

  1. Histamina y fármacos antihistamínicos. Farmacología de otros mediadores inflamatorios

    Velázquez. Farmacología Básica y Clínica (Editorial Médica Panamericana S.A.), pp. 487-500

2003

  1. Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-α by inhibiting nuclear factor-κB activation

    British Journal of Pharmacology, Vol. 138, Núm. 8, pp. 1571-1579

  2. Inhibition of the NF-κB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M

    Biochemical Pharmacology, Vol. 65, Núm. 5, pp. 887-895

2001

  1. Inhibition of acute and chronic inflammatory responses by the hydroxybenzoquinonic derivative rapanone

    Planta Medica, Vol. 67, Núm. 9, pp. 791-795

2000

  1. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 361, Núm. 1, pp. 98-106

  2. New pyridinium alkaloids from a marine sponge of the genus Spongia with a human phospholipase A2 inhibitor profile

    Journal of Natural Products, Vol. 63, Núm. 3, pp. 322-326

1999

  1. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation

    Journal of Pharmacology and Experimental Therapeutics, Vol. 289, Núm. 1, pp. 166-172

  2. Manoalide

    Current Medicinal Chemistry, Vol. 6, Núm. 5, pp. 415-431

  3. Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2

    British Journal of Pharmacology, Vol. 126, Núm. 1, pp. 301-311

1998

  1. A new cacospongionolide inhibitor of human secretory phospholipase A2 from the tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides

    Journal of Natural Products, Vol. 61, Núm. 7, pp. 931-935

  2. Anti-inflammatory activity in mice of extracts from Mediterranean marine invertebrates

    Life Sciences, Vol. 62, Núm. 9

  3. Petrosaspongiolides M-R: New potent and selective phospholipase A2 inhibitors from the new Caledonian marine sponge Petrosaspongia nigra

    Journal of Natural Products, Vol. 61, Núm. 5, pp. 571-575

  4. Suppression of leukotriene B4 and tumour necrosis factor α release in acute inflammatory responses by novel prenylated hydroquinone derivatives

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 357, Núm. 5, pp. 565-572

  5. Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues

    Journal of Medicinal Chemistry, Vol. 41, Núm. 17, pp. 3232-3238

1997

  1. Erratum: Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity (Biochemical Pharmacology (1997) 53 (733-740))

    Biochemical Pharmacology

  2. Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity

    Biochemical Pharmacology, Vol. 53, Núm. 5, pp. 733-740

  3. Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch

    British Journal of Pharmacology, Vol. 120, Núm. 8, pp. 1445-1452